tiprankstipranks
Trending News
More News >
Matinas BioPharma Holdings (MTNB)
:MTNB
US Market

Matinas BioPharma (MTNB) Financial Statements

Compare
1,526 Followers

Matinas BioPharma Financial Overview

Matinas BioPharma's market cap is currently $4.44M. The company's EPS TTM is $-0.326; its P/E ratio is ―; Matinas BioPharma is scheduled to report earnings on May 8, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 1.10M$ 3.19M$ 33.33K$ 158.33K
Gross Profit$ 0.00$ -13.39M$ -13.49M$ -748.16K$ -14.20M
Operating Income$ -24.59M$ -23.77M$ -24.59M$ -24.73M$ -24.21M
EBITDA$ -23.36M$ -22.82M$ -24.23M$ -24.45M$ -23.92M
Net Income$ -24.25M$ -22.94M$ -13.02M$ -21.17M$ -20.60M
Balance Sheet
Cash & Short-Term Investments$ 7.28M$ 13.76M$ 28.76M$ 49.62M$ 58.68M
Total Assets$ 12.64M$ 25.10M$ 44.82M$ 61.33M$ 70.97M
Total Debt$ 2.89M$ 3.56M$ 4.12M$ 4.70M$ 3.75M
Net Debt$ -4.39M$ -1.23M$ -2.71M$ -16.33M$ -8.68M
Total Liabilities$ 5.05M$ 5.86M$ 8.18M$ 8.83M$ 7.24M
Stockholders' Equity$ 7.59M$ 19.25M$ 36.64M$ 52.49M$ 63.73M
Cash Flow
Free Cash Flow$ -15.88M$ -15.50M$ -20.05M$ -15.48M$ -17.37M
Operating Cash Flow$ -15.88M$ -15.28M$ -19.16M$ -15.22M$ -17.37M
Investing Cash Flow$ 9.21M$ 13.24M$ 4.88M$ 16.77M$ -40.67M
Financing Cash Flow$ 9.17M$ -7.00K$ 79.00K$ 6.96M$ 48.05M
Currency in USD

Matinas BioPharma Earnings and Revenue History

Matinas BioPharma Debt to Assets

Matinas BioPharma Cash Flow

Matinas BioPharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis